Page last updated: 2024-08-26

artenimol and Bile Duct Cancer

artenimol has been researched along with Bile Duct Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hu, H; Li, K; Liu, X; Tan, C; Wang, Z; Zhang, H1
Ferraresi, A; Isidoro, C; Loilome, W; Namwat, N; Thongchot, S; Vidoni, C; Yongvanit, P1

Other Studies

2 other study(ies) available for artenimol and Bile Duct Cancer

ArticleYear
Dihydroartemisinin/miR-29b combination therapy increases the pro-apoptotic effect of dihydroartemisinin on cholangiocarcinoma cell lines by regulating Mcl-1 expression.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2020, Volume: 29, Issue:8

    Topics: Apoptosis; Artemisinins; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Myeloid Cell Leukemia Sequence 1 Protein

2020
Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway.
    Molecular carcinogenesis, 2018, Volume: 57, Issue:12

    Topics: Artemisia annua; Artemisinins; Autophagy; Beclin-1; Bile Duct Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Death-Associated Protein Kinases; Gene Expression Regulation, Neoplastic; Humans; Proto-Oncogene Proteins c-bcl-2; Signal Transduction

2018